Increased leucine-rich repeats and immunoglobulin-like domains 1 expression enhances chemosensitivity in glioma
Increased leucine-rich repeats and immunoglobulin-like domains 1 expression enhances chemosensitivity in glioma
复制标题
富含亮氨酸重复序列和免疫球蛋白样结构域 1 表达的增加可增强神经胶质瘤的化疗敏感性
DOI:
10.3969/j.issn.1673-5374.2011.32.007
复制
发表时间:
2011-11-15
影响因子:
6.1
通讯作者:
Yan, Mingmin
中科院分区:
文献类型:
--
作者:
Liu, Baohui;Chen, Qianxue;Yan, Mingmin
Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) is an anti-oncogene. LRIG1 is correlated with Bcl-2 in ependymonnas. Decreased Bcl-2 and manganese superoxide dismutase expression can improve the chennosensitivity of glioma. In the present study, a tissue microarray of human brain astrocytomas was constructed. To investigate the relationship of LRIG1 with Bcl-2 and manganese superoxide dismutase, LRIG1, Bcl-2 and manganese superoxide dismutase expression in our tissue microarray was determined using immunohistochemistry. In addition, we constructed the LRIG1-U251 cell line, and its responses to doxorubicin and temozolomide were detected using the MTT assay. Results showed that LRIG1 expression was significantly negatively correlated with Bcl-2 and manganese superoxide dismutase expression in glioma. Also, proliferation of LRIG1-U251 cells exposed to doxorubicin or temozolomide was significantly inhibited, i.e. in the LRIG1-U251 cell line, the chemosensitivity to doxorubicin and temozolomide was increased. This indicates that increased LRIG1 expression produces a chemosensitivity in glioma.